Where Technology meets Opportunity in Science and Engineering
Power At your Finger Tips
Click category or weSRCH domain below to read news from each weSRCH domain
High Tech :- Business, Consumer, Displays, IT, Mobile, Photo, Semiconductors
Medicine :- Biology, Biotech/Pharma, Equipment, Imaging, Implants, Practice Mngmnt, Therapy, Veterinary
Green Tech :- Battery & Fuel, Biomass, Environmental, Fossil/Nuclear, Lighting, Solar, Trans, Wind/Water/Geo
Business :- Companies, Entrepreneurial, IP/Law, Leadership & Strategy, Management, Sales & Marketing, Social Innovation

Latest News, Top News, Breaking News


    Total record(s) 1227 , Page No. 1 , Max 20 Records Per Page -
    Page Nos. 1 2 3 4 5 6 7 8 9 10 .... Next >>
     

    76% of Patients Face Barriers to Self-Care, Health Improvement - PatientEngagementHIT.com

      The survey, completed by over 2,000 adult patients, found a number of common barriers to patient wellness and independent health maintenance, including a lack of motivation and time, the cost of care, a Save |  Share  Email 21st Sep 2016 
     

    More breast cancer patients should get radiation, new guidelines say - Medical Xpress

      Medical Xpress (HealthDay)-New guidelines issued by three leading cancer organizations suggest that more breast cancer patients should get radiation therapy after a mastectomy. Overall, the guidelines say there's e Save |  Share  Email 21st Sep 2016 
     

    Health Insurance Acquisitions Impede Competition in 24 States - HealthPayerIntelligence.com

      The study used data from 2014 based on commercial enrollment in health maintenance organizations (HMO), preferred provider organizations (PPO), consumer-driven health plans and point-of-service (POS) plans. When Save |  Share  Email 21st Sep 2016 
     

    Immunotherapy-related Pneumonitis More Common With Combo Therapy - Cancer Therapy Advisor

      Pneumonitis associated with PD-1/PD-L1 monoclonal antibodies is more common when given in combination with anti-CTLA-4 monoclonal antibodies. Pneumonitis associated with anti-programmed death-1 (PD-1)/programmed d Save |  Share  Email 21st Sep 2016 
     

    Buffalo Hybridge Free Implant Seminar - WKBW-TV

      WKBW-TV Hybridge dental implants solve a wide range of complex dental problems. Dr. Robert J. Meisner and the team at Buffalo Hybridge can restore your dental health and quality of life with this nationally-recognized, proven and simplified approach to a w Save |  Share  Email 21st Sep 2016 
     

    Cīinii cu st?pīn - Dilema veche

      Dilema veche Cīnd partea de ora? īn care vie?uiesc a fost eliberat? de sub ?asediul" cīinilor comunitari, m?rturisesc c? am respirat u?urat. Omniprezen?a lor m? irita, iar pe so?ia mea o īnfrico?a de-a dreptul. Īns? habar n-aveam c? bietele patrupede Save |  Share  Email 21st Sep 2016 
     

    Randomized trial, registry may provide answers on optimal revascularization approach for CLI - Healio

      All patients are candidates for either surgical or endovascular revascularization. The patients are divided into two cohorts: those with a single-segment great saphenous vein (n = 1,620) and those with Save |  Share  Email 21st Sep 2016 
     

    Secretary Liz Dudek to retire from AHCA - SaintPetersBlog (blog)

      SaintPetersBlog (blog) Dudek departs in the wake of the discovery of the agency's years-long $377 million billing error, in which it systematically - and apparently unknowingly - underpaid the state's Medicaid health maintenance or Save |  Share  Email 21st Sep 2016 
     

    Will Microsoft Corporation (MSFT) Succeed in Oncology Treatment? - TCC

      TCC According to Microsoft Corporation (NASDAQ:MSFT), the company is working on research and development to ascertain the treatment of cancer ailments in relation to the artificial intelligence. The company believes that a Save |  Share  Email 21st Sep 2016 
     

    Clovis Oncology Charts Suggest Aggressive Buying - TheStreet.com

      TheStreet.com Takeover stories and rumors have been the stock-in-trade of Wall Street ever since people could wink and nod. Merger-and-acquisition deals are akin to crack (not that I personally know anything about it). You come into the of Save |  Share  Email 21st Sep 2016 
     

    Immune Checkpoint Inhibitors Continue to Transform Management of Advanced NSCLC - Cancer Therapy Advisor

      Justin F. Gainor, MD, of Massachusetts General Hospital in Boston, and colleagues recently published a review of immune checkpoint inhibitors in NSCLC in The Oncologist.1 Cancer Therapy Advisor spok Save |  Share  Email 21st Sep 2016 
     

    Azithromycin for acute exacerbations of asthma - Pharmacy Today, American Pharmacists Association, pharmacist.com

      U.K. researchers investigated whether combining azithromycin with usual care offers a clinical benefit during asthma attacks. The Azithromycin Against Placebo in Exacerbations of Asthma (AZ Save |  Share  Email 21st Sep 2016 
     

    Kura Oncology Inc. (KURA) Lowered to "Sell" at Zacks Investment Research - The Cerbat Gem

      Zacks Investment Research downgraded shares of Kura Oncology Inc. (NASDAQ:KURA) from a hold rating to a sell rating in a research report report published on Tuesday. According to Zacks, "Kura Oncology, I Save |  Share  Email 21st Sep 2016 
     

    It's World Alzheimer's Day, Mississippians Raise Awareness - Mississippi Public Broadcasting (blog)

      Mississippi Public Broadcasting (blog) More than 52,000 Mississippians are living with Alzheimers disease and the numbers are expected to climb. Fifty-eight year old Lisa Cumbest Michiels says she Save |  Share  Email 21st Sep 2016 
     

    Androgen and Radiation Therapy May Improve Cancer Outcomes - MENAFN.COM

      Some men enrolled in the study underwent six months of androgen suppression therapy administered along with radiation therapy. Other study participants were only given radiation at first. As it turned out, over the course of seven Save |  Share  Email 21st Sep 2016 
     

    AstraZeneca Withdraws EU Application for Ovarian-Cancer Therapy - Bloomberg

      AstraZeneca Plc said it is withdrawing an application for European approval for an ovarian-cancer medicine following disagreement with regulatory authorities. The decision won't affect the ongoing development of Save |  Share  Email 21st Sep 2016 
     

    Aradigm to Host Analyst Meeting and Webcast on September 26 in ... - Business Wire (press release)

      Aradigm will host an Analyst Meeting/Webcast on Sep 26 on Non-Cystic Fibrosis Bronchiectasis featuring presentations by two key opinion leaders:David.and more » Save |  Share  Email 21st Sep 2016 
     

    Eleven Biotherapeutics Acquires Viventia Bio to Create Targeted Protein Therapeutics Oncology Company - Business Wire (press release)

      The acquisition creates a NASDAQ-listed company focused on the development of novel therapies based upon antibody fragments genetically fused to cytotoxic proteins, or t Save |  Share  Email 21st Sep 2016 
     

    Aradigm to Host Analyst Meeting and Webcast on September 26 in New York City - Business Wire (press release)

      Dr. Griffith is board-certified in Internal Medicine and Pulmonary Disease. Gregory Tino, MD, is an Associate Professor of Medicine at the Perelman School of Medicine at the University of Pennsy Save |  Share  Email 21st Sep 2016 
     

    Credit Suisse Upgrades Clovis Oncology (CLVS) to Outperform on Takeout Potential - StreetInsider.com

      BBNS Credit Suisse upgraded Clovis Oncology (NASDAQ: CLVS) from Neutral to Outperform with a price target of $41.00 (from $19.00). Analyst Kennen MacKay commented, "We upgrade CLVS to OUTPERFORM fro Save |  Share  Email 21st Sep 2016 
     
    Total record(s) 1227 , Page No. 1 , Max 20 Records Per Page -
    Page Nos. 1 2 3 4 5 6 7 8 9 10 .... Next >>
     
    Subscribe
    x